Correlation Between Vate Technology and TTY Biopharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vate Technology and TTY Biopharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vate Technology and TTY Biopharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vate Technology Co and TTY Biopharm Co, you can compare the effects of market volatilities on Vate Technology and TTY Biopharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vate Technology with a short position of TTY Biopharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vate Technology and TTY Biopharm.

Diversification Opportunities for Vate Technology and TTY Biopharm

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Vate and TTY is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Vate Technology Co and TTY Biopharm Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TTY Biopharm and Vate Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vate Technology Co are associated (or correlated) with TTY Biopharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TTY Biopharm has no effect on the direction of Vate Technology i.e., Vate Technology and TTY Biopharm go up and down completely randomly.

Pair Corralation between Vate Technology and TTY Biopharm

Assuming the 90 days trading horizon Vate Technology Co is expected to under-perform the TTY Biopharm. In addition to that, Vate Technology is 3.92 times more volatile than TTY Biopharm Co. It trades about -0.01 of its total potential returns per unit of risk. TTY Biopharm Co is currently generating about -0.04 per unit of volatility. If you would invest  8,120  in TTY Biopharm Co on September 4, 2024 and sell it today you would lose (570.00) from holding TTY Biopharm Co or give up 7.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vate Technology Co  vs.  TTY Biopharm Co

 Performance 
       Timeline  
Vate Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vate Technology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Vate Technology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
TTY Biopharm 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in TTY Biopharm Co are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, TTY Biopharm is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Vate Technology and TTY Biopharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vate Technology and TTY Biopharm

The main advantage of trading using opposite Vate Technology and TTY Biopharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vate Technology position performs unexpectedly, TTY Biopharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TTY Biopharm will offset losses from the drop in TTY Biopharm's long position.
The idea behind Vate Technology Co and TTY Biopharm Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account